BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27771689)

  • 1. Immune Thrombocytopenia Following Diphtheria Pertussis- Tetanus and Oral Polio Vaccine.
    Bhowmik A; Biswas T
    Indian Pediatr; 2016 Oct; 53(10):934-935. PubMed ID: 27771689
    [No Abstract]   [Full Text] [Related]  

  • 2. Childhood lichen planus after simultaneous measles-mumps-rubella and diphtheria-tetanus-pertussis-polio vaccinations.
    Tasanen K; Renko M; Kandelberg P; Herva R; Oikarinen A
    Br J Dermatol; 2008 Mar; 158(3):646-8. PubMed ID: 18081897
    [No Abstract]   [Full Text] [Related]  

  • 3. Pityriasis rubra pilaris occurring after vaccination with diphtheria-pertussis-tetanus and oral poliovirus vaccines.
    Mohamed M; Belhadjali H; Hammedi F; Ben Meriem C; Zili J
    Indian J Dermatol Venereol Leprol; 2015; 81(6):618-20. PubMed ID: 26515846
    [No Abstract]   [Full Text] [Related]  

  • 4. DPT-OPV immunization and sudden infant death syndrome.
    John TJ
    Indian Pediatr; 1997 Nov; 34(11):1045-6. PubMed ID: 9567540
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse reactions to vaccine: Italian cases in the quinquennium 1986-1990.
    Squarcione S; Vellucci L; Parisi P; D'Amato S; Serio G
    Ann Ig; 1993; 5(2):81-90. PubMed ID: 7510978
    [No Abstract]   [Full Text] [Related]  

  • 6. [The immunogenicity of vaccines against diphtheria, tetanus, pertussis and polio administered orally on the vaccinal calendar at the age of 2, 4 and 6 months and their coadministration with a hepatitis B vaccine at 0, 2 and 6 months].
    Arístegui Fernández J; Muñiz Saitua J; Pérez Legorburu A; Imaz Pérez M; Arrate Zugazabeitia JP; Suárez Fernández MD; Goiri Zabala MD
    An Esp Pediatr; 1996 Jan; 44(1):25-8. PubMed ID: 8849056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute immune thrombocytopenic purpura as adverse reaction to oral polio vaccine (OPV).
    Jin CQ; Dong HX; Sun ZX; Zhou JW; Dou CY; Lu SH; Yang RR
    Hum Vaccin Immunother; 2013 Aug; 9(8):1739-40. PubMed ID: 23807364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Encephalitis after simultaneous DPT and oral trivalent poliomyelitis (Sabin vaccine) and HiB preventive vaccination?].
    Wiersbitzky S; Schröder C; Griefahn B; Käding M; Wiersbitzky H; Anders C; Seidel W; Mendel R
    Kinderarztl Prax; 1993 Jun; 61(4-5):172-3. PubMed ID: 8103131
    [No Abstract]   [Full Text] [Related]  

  • 9. Pre-discharge immunization among hospitalized Filipino children.
    Capeding MR; Lazaro JA; Kaneko YY
    Pediatr Infect Dis J; 1990 Aug; 9(8):570-3. PubMed ID: 2235173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cerebral seizures and/or encephalitis after MMR, oral polio, HiB or DPT vaccination?].
    Wiersbitzky S; Bruns R; Schmidt U
    Kinderarztl Prax; 1993 Aug; 61(6):232-4. PubMed ID: 8105136
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adults.
    Kovac M; Rathi N; Kuriyakose S; Hardt K; Schwarz TF
    Vaccine; 2015 May; 33(22):2594-601. PubMed ID: 25882172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute transverse myelitis in a 7-month-old boy after diphtheria-tetanus-pertussis immunization.
    Riel-Romero RM
    Spinal Cord; 2006 Nov; 44(11):688-91. PubMed ID: 16317420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip) to adults aged ≥60 years: an open-label, randomised trial.
    Zimmermann U; Gavazzi G; Richard P; Eymin C; Soubeyrand B; Baudin M
    Vaccine; 2013 Mar; 31(11):1496-502. PubMed ID: 23313654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
    Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
    Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine.
    Cheng HK; Rajadurai VS; Amin Z; Sriram B; Yee MF; Han HH; Bock HL; Safary A
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):685-92. PubMed ID: 15689088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children.
    Collins CL; Salt P; McCarthy N; Chantler T; Lane L; Hemme F; Diggle L; Buttery J; Kitchin NR; Moxon ER; Pollard AJ
    Vaccine; 2004 Oct; 22(31-32):4262-9. PubMed ID: 15474717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization.
    Agnandji ST; Asante KP; Lyimo J; Vekemans J; Soulanoudjingar SS; Owusu R; Shomari M; Leach A; Fernandes J; Dosoo D; Chikawe M; Issifou S; Osei-Kwakye K; Lievens M; Paricek M; Apanga S; Mwangoka G; Okissi B; Kwara E; Minja R; Lange J; Boahen O; Kayan K; Adjei G; Chandramohan D; Jongert E; Demoitié MA; Dubois MC; Carter T; Vansadia P; Villafana T; Sillman M; Savarese B; Lapierre D; Ballou WR; Greenwood B; Tanner M; Cohen J; Kremsner PG; Lell B; Owusu-Agyei S; Abdulla S
    J Infect Dis; 2010 Oct; 202(7):1076-87. PubMed ID: 20735271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postvaccination bullous pemphigoid in infancy: report of three new cases and literature review.
    de la Fuente S; Hernández-Martín Á; de Lucas R; González-Enseñat MA; Vicente A; Colmenero I; González-Beato M; Suñol M; Torrelo A
    Pediatr Dermatol; 2013; 30(6):741-4. PubMed ID: 24125034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines and unexpected observations: flaws or cause for concern?
    Aaby P; Rodrigues A; Biai S; Martins C; Veirum JE; Benn CS; Jensen H
    Vaccine; 2005 Mar; 23(19):2407-8. PubMed ID: 15752826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.